ArticleTheranostics2020

Therapeutic targeting of YY1/MZF1 axis by MZF1-uPEP inhibits aerobic glycolysis and neuroblastoma progression.

Erhu Fang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.